Literature DB >> 12949238

Expression of IL-2 receptor beta and gamma chains by human gingival fibroblasts and up-regulation of adhesion to neutrophils in response to IL-2.

Akiko Ozawa1, Hiroyuki Tada, Riyoko Tamai, Akiko Uehara, Kouichi Watanabe, Takahiro Yamaguchi, Hidetoshi Shimauchi, Haruhiko Takada, Shunji Sugawara.   

Abstract

To investigate the role of human gingival fibroblasts (HGF), the major constituents of gingival tissue in periodontal inflammatory disease, the expression of interleukin-2 receptor (IL-2R) alpha, beta, and gamma chains was examined. Immunohistochemistry showed a pronounced accumulation of CD8(+) T cells in the inflamed lamina propria of gingival tissue from patients with adult periodontitis. HGF express IL-2Rbeta and IL-2Rgamma at mRNA and protein levels, but the expression of IL-2Ralpha could not be detected, as assessed by reverse transcriptase-polymerase chain reaction and flow cytometry. IL-2Rbeta, and -gamma expressed on HGF were functionally active, as addition of neutralizing anti-IL-2Rbeta and -gamma antibodies caused inhibition of the IL-2-induced production of monocyte chemoattractant protein-1 (MCP-1), and addition of IL-2 induced phosphorylation of Janus tyrosine kinase 3, which is critical in signaling through IL-2Rgamma in HGF. The IL-2-induced MCP-1 production was significantly inhibited by pretreatment with neutralizing antibody to IL-15. Addition of IL-2 also induced a marked up-regulation of the expression of intercellular adhesion molecule-1 (ICAM-1) on the surface of HGF, which in turn, significantly augmented the adhesion of human neutrophils, which were inhibited by an anti-ICAM-1 antibody. These results suggest that HGF express functional IL-2Rbetagamma, respond to IL-2 from infiltrated T cells, and actively participate in the inflammatory process in the periodontal region and that IL-15 produced by HGF sustains IL-2-mediated signaling in HGF.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12949238     DOI: 10.1189/jlb.0103044

Source DB:  PubMed          Journal:  J Leukoc Biol        ISSN: 0741-5400            Impact factor:   4.962


  7 in total

1.  Cytokines differentially regulate ICAM-1 and VCAM-1 expression on human gingival fibroblasts.

Authors:  Y Hosokawa; I Hosokawa; K Ozaki; H Nakae; T Matsuo
Journal:  Clin Exp Immunol       Date:  2006-06       Impact factor: 4.330

2.  Control of matrix metalloproteinase production in human intestinal fibroblasts by interleukin 21.

Authors:  G Monteleone; R Caruso; D Fina; I Peluso; V Gioia; C Stolfi; M C Fantini; F Caprioli; R Tersigni; L Alessandroni; T T MacDonald; F Pallone
Journal:  Gut       Date:  2006-05-08       Impact factor: 23.059

Review 3.  The contribution of interleukin-2 to effective wound healing.

Authors:  Karen M Doersch; Daniel J DelloStritto; M Karen Newell-Rogers
Journal:  Exp Biol Med (Maywood)       Date:  2016-10-25

4.  The extracellular and transmembrane domains of the γC and interleukin (IL)-13 receptor α1 chains, not their cytoplasmic domains, dictate the nature of signaling responses to IL-4 and IL-13.

Authors:  Nicola M Heller; Xiulan Qi; Franck Gesbert; Achsah D Keegan
Journal:  J Biol Chem       Date:  2012-07-24       Impact factor: 5.157

5.  Autophagy is required for IL-2-mediated fibroblast growth.

Authors:  Rui Kang; Daolin Tang; Michael T Lotze; Herbert J Zeh Iii
Journal:  Exp Cell Res       Date:  2012-11-27       Impact factor: 3.905

Review 6.  Pleiotropic Effects of IL-2 on Cancer: Its Role in Cervical Cancer.

Authors:  Arturo Valle-Mendiola; Adriana Gutiérrez-Hoya; María del Carmen Lagunas-Cruz; Benny Weiss-Steider; Isabel Soto-Cruz
Journal:  Mediators Inflamm       Date:  2016-05-12       Impact factor: 4.711

7.  Expression of inflammatory mediators in biofilm samples and clinical association in inflammatory bowel disease patients-a preliminary study.

Authors:  Mayte Buchbender; Jakob Fehlhofer; Peter Proff; Tobias Möst; Jutta Ries; Matthias Hannig; Markus F Neurath; Madline Gund; Raja Atreya; Marco Kesting
Journal:  Clin Oral Investig       Date:  2021-08-12       Impact factor: 3.573

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.